Wall Street brokerages expect that IntriCon Co. (NASDAQ:IIN) will announce sales of $26.12 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for IntriCon’s earnings. The lowest sales estimate is $25.70 million and the highest is $26.54 million. IntriCon posted sales of $30.81 million during the same quarter last year, which suggests a negative year-over-year growth rate of 15.2%. The firm is scheduled to announce its next earnings results on Tuesday, February 18th.
On average, analysts expect that IntriCon will report full-year sales of $112.22 million for the current financial year, with estimates ranging from $112.10 million to $112.34 million. For the next fiscal year, analysts expect that the company will post sales of $121.73 million, with estimates ranging from $118.30 million to $125.16 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover IntriCon.
IntriCon (NASDAQ:IIN) last released its quarterly earnings results on Monday, November 4th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.04). The firm had revenue of $26.89 million for the quarter, compared to analysts’ expectations of $27.68 million. IntriCon had a positive return on equity of 1.81% and a negative net margin of 3.14%.
NASDAQ:IIN traded up $0.32 during mid-day trading on Monday, reaching $18.87. 93,000 shares of the stock were exchanged, compared to its average volume of 139,429. The company has a 50 day simple moving average of $19.12 and a 200-day simple moving average of $20.35. The stock has a market capitalization of $162.24 million, a P/E ratio of 29.48, a P/E/G ratio of 18.12 and a beta of 0.66. The company has a quick ratio of 2.33, a current ratio of 3.19 and a debt-to-equity ratio of 0.04. IntriCon has a 1 year low of $16.81 and a 1 year high of $30.00.
Several hedge funds have recently made changes to their positions in IIN. Bard Associates Inc. lifted its holdings in shares of IntriCon by 4.9% in the 2nd quarter. Bard Associates Inc. now owns 28,195 shares of the technology company’s stock valued at $659,000 after buying an additional 1,325 shares during the period. Vanguard Group Inc. lifted its holdings in shares of IntriCon by 0.4% in the 2nd quarter. Vanguard Group Inc. now owns 420,572 shares of the technology company’s stock valued at $9,825,000 after buying an additional 1,470 shares during the period. Usca Ria LLC acquired a new stake in shares of IntriCon in the 3rd quarter valued at approximately $31,000. California Public Employees Retirement System lifted its holdings in shares of IntriCon by 5.8% in the 3rd quarter. California Public Employees Retirement System now owns 34,616 shares of the technology company’s stock valued at $673,000 after buying an additional 1,900 shares during the period. Finally, AdvisorNet Financial Inc acquired a new stake in shares of IntriCon in the 3rd quarter valued at approximately $46,000. Institutional investors own 80.04% of the company’s stock.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Article: Earnings Reports
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.